Nortis, Inc.

20 employees

Nortis is developing the next generation of invitro systems that will allow scientists to better understand the causes of human diseases.

Basic info

biotechnology research

Biotechnology

Preclinical studies

Personalized medicine

3D cell culture

Drug Screening

Tumor microenvironment models

Reduce

Refine

Drug development

In-vitro testing

OoC

Replace

Liver models

High Content Screening

Biopharma

Tissue models

Tissue Engineering

Oncology models

Disease models

Microphysiological systems

Cell based assays

Kidney models

Microfluidics

Contract research

Organs-on-Chip

Medical

2012